Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive perspective. Advocates often emphasize the possibility for substantial therapeutic outcomes, principally in conditions where conventional therapies have proven inadequate. However, crucially important to assess the substantial financial expenditure associated with